CV CVS CVS Health Corporation Loading... : Investor Sentiment and Bull/Bear Views

CVS has pulled back too far on proposed 340B reimbursement changes and Caremark PBM concerns; the actual quarter was strong, earnings growth remains on track, and at 11 times earnings the stock is too cheap to ignore.

CVS is listed among the author's current holdings and also appears on his long model list. He is still almost 40% long and bullish medium term on earnings and potential rate and oil relief. The stated risk is the cautious model signal, which he is using as a reason to wait.

The author argues that escalating US tariffs on India over Russian oil purchases risk disrupting the large volumes of medications, electrical machinery, electronics, telecom equipment and pharmaceuticals the US imports from India. Because CVS relies heavily on Indian-sourced generic drugs, supply disruption would pressure its business, making puts on CVS the play. The catalyst is the tariff threat and India's defiant response; the main risk is that a negotiated settlement avoids any supply impact.